DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Doxil (Doxorubicin) - Ovarian Cancer Recurrent - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Ovarian Cancer Recurrent (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Doxil (Doxorubicin) where reactions include ovarian cancer recurrent. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Doxil side effects in female

Reported by a physician from Japan on 2012-05-30

Patient: female

Reactions: Ovarian Cancer Recurrent, Pneumonia, Aspartate Aminotransferase Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Doxil
    Dosage: cycle 2
    Indication: Ovarian Cancer Recurrent
    Start date: 2010-04-28
    End date: 2010-04-28

Doxil
    Dosage: cycle 1
    Start date: 2010-03-31
    End date: 2010-03-31

Doxil
    Dosage: cycle 3
    Start date: 2010-05-26
    End date: 2010-05-26

Lipidil
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Doxil
    Dosage: cycle 4
    Start date: 2010-06-30
    End date: 2010-06-30

Doxil
    Dosage: cycle 5
    Start date: 2010-08-04
    End date: 2010-08-04

Other drugs received by patient: Loxoprofen Sodium; Clobetasol Propionate; Pursennid; Azunol; Zofran; Eurax; Mucosta; Loxoprofen Sodium; Cyanocobalamin; Oxatomide; Decadron; White Petrolatum; Hirudoid Cream; Granisetron; Premarin; Atarax; Myser; Lecicarbon; Decadron



Possible Doxil side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-22

Patient: female

Reactions: Drug Dose Omission, Cholelithiasis, Death, Vomiting, Ovarian Cancer Recurrent, Nausea

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxil
    Indication: Ovarian Cancer
    Start date: 2011-01-01
    End date: 2011-01-01

Doxil
    Start date: 2011-01-01
    End date: 2011-01-01

Topotecan
    Indication: Ovarian Cancer
    Start date: 2011-01-01



Possible Doxil side effects in female

Reported by a physician from Japan on 2012-04-10

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Ovarian Cancer Recurrent, Interstitial Lung Disease

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Doxil
    Dosage: cycle 1
    Start date: 2009-06-03
    End date: 2009-06-03

Docetaxel
    Dosage: 3 cycles completed
    End date: 2009-03-01

Docetaxel
    Dosage: 5 cycles completed
    Indication: Ill-Defined Disorder
    End date: 2008-11-13

Doxil
    Dosage: cycle 2
    Indication: Ovarian Cancer Recurrent
    Start date: 2009-07-01
    End date: 2009-07-01

Gemcitabine
    Dosage: 3 cycles completed
    Indication: Ill-Defined Disorder
    End date: 2009-03-24

Other drugs received by patient: Decadron; Ramosetron Hydrochloride; Thiamine Monophosphate Disulfide; Decadron; Decadron; Astomin; Azunol



Possible Doxil side effects in female

Reported by a physician from Japan on 2012-04-10

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Ovarian Cancer Recurrent, Interstitial Lung Disease

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Doxil
    Dosage: cycle 1
    Start date: 2009-06-12
    End date: 2009-06-12

Doxil
    Dosage: cycle 2
    Start date: 2009-07-10
    End date: 2009-07-10

Doxil
    Dosage: cycle 4
    Start date: 2009-09-04
    End date: 2009-09-04

Doxil
    Dosage: cycle 3
    Indication: Ovarian Cancer Recurrent
    Start date: 2009-08-07
    End date: 2009-08-07

Other drugs received by patient: Decadron; Decadron; Gran; Daio-Kanzo-TO; Azunol; Decadron; Decadron; Sunrythm; Decadron; Thiamine Monophosphate Disulfide; Thiamine Monophosphate Disulfide; Meiact; Decadron; Decadron; Thiamine Monophosphate Disulfide; Gemcitabine Hydrochloride; Decadron; Ramelteon; Thiamine Monophosphate Disulfide; Zolpidem; Decadron; Decadron; Banan; Ramelteon; Ramelteon; Ramelteon



Possible Doxil side effects in female

Reported by a physician from Japan on 2012-04-05

Patient: female, weighing 57.0 kg (125.4 pounds)

Reactions: Ovarian Cancer Recurrent, Ileus, Ascites

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxil
    Start date: 2010-02-19
    End date: 2010-02-19

Doxil
    Indication: Ovarian Cancer Recurrent
    Start date: 2010-03-19
    End date: 2010-03-19

Other drugs received by patient: Iodine; Amino Acid INJ; Primperan TAB; Lasix; Lasix; Famotidine; Soldem 3A; Flumarin; Famotidine; Famotidine; Xylocaine; Glycyron; Famotidine; Flurbiprofen; Ascorbic Acid; Loxonin; Primperan TAB; Vitamedin; Mucosta; Lasix; Azunol; Ceftriaxone Sodium; Amikamycin



Possible Doxil side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-26

Patient: female, weighing 56.7 kg (124.7 pounds)

Reactions: Ovarian Cancer Recurrent, Mass

Drug(s) suspected as cause:
Doxil



Possible Doxil side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-29

Patient: female, weighing 56.7 kg (124.7 pounds)

Reactions: Ovarian Cancer Recurrent, Mass

Drug(s) suspected as cause:
Doxil



Possible Doxil side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-07

Patient: female, weighing 56.7 kg (124.7 pounds)

Reactions: Ovarian Cancer Recurrent, Mass, Neoplasm Progression

Drug(s) suspected as cause:
Doxil



Possible Doxil side effects in female

Reported by a physician from Japan on 2012-01-18

Patient: female, weighing 47.0 kg (103.4 pounds)

Reactions: Ovarian Cancer Recurrent, Retinal Haemorrhage

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxil
    Dosage: cycle 5
    Start date: 2010-04-28
    End date: 2010-04-28

Doxil
    Dosage: cycle 6
    Start date: 2010-05-26
    End date: 2010-05-26

Doxil
    Dosage: cycle 2
    Indication: Ovarian Cancer Recurrent
    Start date: 2010-02-03
    End date: 2010-02-03

Doxil
    Dosage: cycle 3
    Start date: 2010-03-03
    End date: 2010-03-03

Doxil
    Dosage: cycle 1
    Start date: 2010-01-08
    End date: 2010-01-08

Doxil
    Dosage: cycle4
    Start date: 2010-03-31
    End date: 2010-03-31

Other drugs received by patient: Ramelteon; Sodium Bicarbonate; Nerisona; Nicotinamide; Goreisan; Olopatadine HCL; Allegra; Pydoxal; Cinal; DAI-Kenchu-TO; Magnesium Sulfate; Minocycline HCL; Kenalog; Loxonin; Amoban; Rinderon-VG

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017